Open Access Green as soon as Postprint is submitted to ZB.
Liver-fibrosis-activated transcriptional networks govern hepatocyte reprogramming and intra-hepatic communication.
Cell Metab. 33, 1685-1700.e9 (2021)
Publ. Version/Full Text
Research data
DOI
PMC
Liver fibrosis is a strong predictor of long-term mortality in individuals with metabolic-associated fatty liver disease; yet, the mechanisms underlying the progression from the comparatively benign fatty liver state to advanced non-alcoholic steatohepatitis (NASH) and liver fibrosis are incompletely understood. Using cell-type-resolved genomics, we show that comprehensive alterations in hepatocyte genomic and transcriptional settings during NASH progression, led to a loss of hepatocyte identity. The hepatocyte reprogramming was under tight cooperative control of a network of fibrosis-activated transcription factors, as exemplified by the transcription factor Elf-3 (ELF3) and zinc finger protein GLIS2 (GLIS2). Indeed, ELF3- and GLIS2-controlled fibrosis-dependent hepatokine genes targeting disease-associated hepatic stellate cell gene programs. Thus, interconnected transcription factor networks not only promoted hepatocyte dysfunction but also directed the intra-hepatic crosstalk necessary for NASH and fibrosis progression, implying that molecular "hub-centered" targeting strategies are superior to existing mono-target approaches as currently used in NASH therapy.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Cell Type-specific Profiling ; Elf3 ; Glis2 ; Genomic Reprogramming ; Hepatocytes ; Liver Fibrosis ; Metabolic-associated Fatty Liver Disease ; Nonalcoholic Steatohepatitis ; Transcription Factor Networks; Gene-expression; Cell Identity; Mouse Model; Steatohepatitis; Osteopontin; Distinct; Inflammation; Association; Homeostasis; Macrophage
ISSN (print) / ISBN
1550-4131
e-ISSN
1932-7420
Journal
Cell Metabolism
Quellenangaben
Volume: 33,
Issue: 8,
Pages: 1685-1700.e9
Publisher
Elsevier
Publishing Place
50 Hampshire St, Floor 5, Cambridge, Ma 02139 Usa
Non-patent literature
Publications
Reviewing status
Peer reviewed
Institute(s)
Institute of Diabetes and Cancer (IDC)
Research Unit Analytical Pathology (AAP)
Institute of Neurogenomics (ING)
Research Unit Analytical Pathology (AAP)
Institute of Neurogenomics (ING)
Grants
NNF
DZD grant NEXT
EMBO Long-Term Fellowship
Danish Independent Research Council | Natural Sciences
Novo Nordisk Foundation (NNF)
Danish National Research Foundation
Deutsche Forschungsge-meinschaft (DFG, German Research Foundation) through the Collaborative Research Center (CRC) 1118
DZD grant NEXT
EMBO Long-Term Fellowship
Danish Independent Research Council | Natural Sciences
Novo Nordisk Foundation (NNF)
Danish National Research Foundation
Deutsche Forschungsge-meinschaft (DFG, German Research Foundation) through the Collaborative Research Center (CRC) 1118